WALTHAM, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies, ...

Late-breaking analysis from pivotal INDIGO Phase 3 trial demonstrates vorasidenib led to tumor shrinkage in IDH1/2-mutant diffuse glioma First data from Phase 1 trial show the safety and tolerability ...

IndiGo’s mass flight cancellations reveal deeper failures in aviation regulation, pilot safety rules, and passenger rights, ...

IndiGo, which was penalised for Rs 5 lakh last week for denying boarding to a specially-abled child at Ranchi airport on May 7, has now decided to conduct an internal case study on how to better ...

BELGIUM - Ghent, March 18, 2021 – Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of medical solutions using nanophotonics, announces that its continuous multi-metabolite ...

Zenas BioPharma Announces First Patient Dosed in Phase 3 Clinical Study of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD) Global Phase 3 INDIGO study will evaluate the ...

The IndiGo CEO said the airline needs to ask itself in situations like this that what can it do about calming the distressed passenger. IndiGo will conduct an internal case study on how to better ...